http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
(활성탄/고분자바인더)복합성형체의 압출온도에 따르는 응집구조 및 유량 상관성에 관한 연구
홍성규 ( Yong Gyun Lim ),임용균 ( Young Jun Kim ),김영준 ( Sang Jin Park ),박상진 ( Sung Kyu Hong ) 한국화학공학회 2014 Korean Chemical Engineering Research(HWAHAK KONGHA Vol.52 No.2
정수처리 방식에 있어서 소형화의 필요성이 증대됨에 따라 복합적인 기능을 갖는 단일구조 여과재 개발이 절실히 요구되고 있다. 본 연구에서는 단일구조를 가지는 필터개발을 위하여 활성탄과 고분자 바인더로 구성된 성형체를 압출소결방식으로 제조하여, 제조된 성형체의 밀도, 공극률 및 유량을 평가하여, 최대유량을 가지는 성형체의 최적 압출온도를 결정하였다. 또한 성형체의 공극률 평가에 있어서 전체 공극률뿐만 아니라 관통형 기공의 공극률을 추가로 평가하여 유량과의 상관성을 평가하였다. 압출온도가 고분자 바인더의 Melting point인 133 oC 이상인 140~230 oC에서단일구조 복합 활성탄 성형체 구성이 가능하였으며, 압출온도 170 oC가 복합성형체의 밀도가 낮고, 관통기공의 공극률이 높아, 최대유량을 가지는 복합성형체의 제조가 가능한 최적 압출온도로 확인되었다. 또한 복합성형체를 통해 흐르는 물의 유량은 성형체의 전체 공극률 보다 관통형 기공의 공극률에 크게 의존함을 알 수 있었다. As the need for miniaturization in water purification filter increases, the development of filter media for single filtration with multiple function was strongly required. In this study, the molded activated carbon composed of single un it was manufactured by extrusion-sintering process, and then the flow rate, density and porosity were investigated using the molded activated carbon manufactured at various extrusion temperature. We confirmed that it was possible to manufacture the single unit-molded activated carbon when the extrusion temperature was 140~230 oC more than 133 oC being of polymer binder melting point, and the optimal extrusion temperature for the molded activated carbon with maximum flow rate was 170 oC since the molded activated carbon had low density and high through porosity. Also we confirmed that the flow rate through the molded activated carbon was strongly dependent upon through pore porosity compared to total porosity for the molded activated carbon.
급성 진정제 중독 추정 환자에서 플루마제닐의 투여: 위험도/이익 재평가
허재홍 ( Jae Hong Huh ),최상천 ( Sang Chun Choi ),임용균 ( Yong Gyun Lim ),샘슨램포탕 ( Samsun Lampotang ),박은정 ( Eung Jung Park ) 대한임상독성학회 2016 대한임상독성학회지 Vol.14 No.2
Purpose: The use of flumazenil administration in the emergency department is still controversial because of concerns about adverse effects. The present study was conducted to re-evaluate the risk-benefit ratio associated with flumazenil administration to patients suspected of having acute hypnotics and sedatives poisoning in the emergency department. Methods: A retrospective chart review study was conducted for patients whose final diagnoses were “poisoning” and “benzodiazepine” or “sedatives-hypnotics” from Mar. 2006 to Feb. 2015. The basal characteristics of the patients, including past medical history, ingredients and dose of ingested drug and co-ingested drugs were investigated. For patients administered flumazenil, responsiveness and time from admission to flumazenil administration were investigated with supplement. All collected data were analyzed in aspect terms of risk/benefit. Results: A total of 678 patients were included in our study. Benzodiazepine was the most common sedative/hypnotic drug prescribed, and the frequency of prescription continuously increased. The proportion of TCA as co-ingestion decreased from 13.1% to 3.9% in patients with acute sedative/hypnotic poisoning. Flumazenil was administered to 55 patients (8.1%), of which 29 patients (52.7%) were applied to contraindications. Fifty-three patients (96.4%) showed positive responsiveness, including partial responsiveness after flumazenil administration. No severe adverse events were identified. Conclusion: Based on the current trends in prescription patterns for sedative/hypnotic drugs, increased use of non- TCA antidepressants, and responsiveness to administration of flumazenil, benefit seemed weighted more in this study, although the observed benefits were based on limited results. Further prospective multicenter studies will be needed to optimize benefit-risk ratio.